Cargando…
The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents
Stroke is the second leading cause of death worldwide and the leading cause of long-term disability that seriously endangers health and quality of human life. Tissue-type fibrinogen activator is currently the only drug approved by FDA for the treatment of ischemic stroke. Neuroprotection is theoreti...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978560/ https://www.ncbi.nlm.nih.gov/pubmed/35387336 http://dx.doi.org/10.3389/fphar.2022.877706 |